• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Daniel B. Costa, MD, PhD

Assistant Professor, Department of Medicine, Harvard Medical School

Medical Staff, Hematology/Oncology, Beth Israel Deaconess Medical Center

Contact Info

Daniel Costa
Beth Israel Deaconess Medical Center
330 Brookline Ave
Boston, MA, 02215
Mailstop: Shapiro 9
Phone: 617-667-9236
Fax: 617-975-5665


Annie Gauger
Administrative Assistant
Beth Israel Deaconess Medical Center
330 Brookline Avenue, Shapiro 9
Boston, MA, 02215
Phone: 617-667-9236
Fax: 617-975-5665

DF/HCC Program Affiliation

Lung Cancer, Co-Leader
Translational Pharmacology and Early Therapeutic Trials

DF/HCC Associations

Member, Center Scientific Council

Research Abstract

Lung cancer is the leading cause of death from cancer in the United States. Better understanding of oncogenes and tumor suppressor genes involved in lung cancer hold the promise of improving clinical care of afflicted patients.

Prior work from our group has focused on transcription factors involved in lung cancer and mechanisms of sensitivity/resistance of oncogene kinases (such as EGFR, ALK, KRAS) to tyrosine kinase inhibitors in non-small-cell lung cancer.

Our group is also part of the clinical research effort at DFHCC, with a focus in non-small-cell lung cancer. We are part of the NIH/NCI-funded SPORE in Lung Cancer at DFHCC.

(co-investigators: Daniel G. Tenen, MD, Mark Huberman, MD and Susumu Kobayashi, MD, PhD)


View All Publications